The goal of this clinical trial is to evaluate if laserpuncture (laser acupuncture) can reduce leucopenia caused by chemotherapy and improve the quality of life in patients with head and neck cancer. The main questions it aims to answer are: * Does laserpuncture reduce the incidence of chemotherapy-induced Leucopenia ? * Does laserpuncture improve quality of life in these patients? Researchers will compare patients receiving laserpuncture therapy to a control group receiving sham laserpuncture to see if the intervention has a beneficial effect. Participants will: * Undergo six sessions of laserpunktur or sham laserpuncture during chemotherapy * Have leukocyte counts and absolute neutrophil counts measured before and 7-14 days after chemotherapy * Complete quality of life assessments using EORTC QLQ-C30 and EORTC QLQ-H\&N35 questionnaires
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
30
The intervention group in this study receives laser acupuncture therapy using a laser Micropad GL2+ device with an infrared wavelength of 880 nm. The laser acupuncture is applied to specific acupuncture points, namely GV14, LI4, ST36, and SP6 on the body, as well as ear points including MA-TF1 Shenmen, MA-SC5 Liver, MA-IC3 Endocrine, MA-IC8 Spleen, and MA-SC6 Kidney. Treatment is administered once daily for a total of six sessions during the chemotherapy treatment period.
The Control group in this study receives sham laser acupuncture therapy using a laser Micropad GL2+ device with deactivation mode. The sham laser acupuncture is applied to specific acupuncture points, namely GV14, LI4, ST36, and SP6 on the body, as well as ear points including MA-TF1 Shenmen, MA-SC5 Liver, MA-IC3 Endocrine, MA-IC8 Spleen, and MA-SC6 Kidney. Treatment is administered once daily for a total of six sessions during the chemotherapy treatment period.
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, Indonesia
Leukocyte Count
Leukocyte count is the measure of the number of white blood cells (leukocytes) present in the blood
Time frame: Before therapy, between 7-14 day after chemoterapy
Absolute Neutrophil Count
The Absolute Neutrophil Count (ANC) is a laboratory measure of the number of neutrophils, a type of white blood cell that plays a critical role in fighting infection, present in the blood.
Time frame: Before therapy, between 7-14 day after chemoterapy
European Organization of Research and Treatment of Cancer Quality of Life Questionnaire- Core 30 questionnaire
Self-reported questionnaire to assess the quality of life of cancer patients.
Time frame: Before therapy, between 7-14 day after chemoterapy
European Organization of Research and Treatment of Cancer Quality of Life Questionnaire Heand &Neck 35 questionnaire
Self-reported questionnaire to assess quality of life specific to patients with head and neck cancer.
Time frame: Before therapy, between 7-14 day after chemoterapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.